Drug or treatment

Sunitinib clinical trials

• 15Clinical trials
• 27Countries

Newest trials

All recruiting trials (15)

• Velzatinib for advanced GIST after multiple prior TKIs

  This study tests velzatinib to see if it can shrink or slow tumors in people with metastatic or unresectable GIST who have progressed on or could not tolerate standard therapies.

  Recruiting at 3 sites Phase 2 GlaxoSmithKline · Fukuoka and 2 other locations · NCT07689201

• Ipalotinib and Sunitinib with Olaparib before surgery for HRD-positive advanced ovarian cancer

  This trial tests a neoadjuvant therapy combo in HRD-positive advanced ovarian cancer to see if it helps shrink tumors before surgery.

  Recruiting Phase 2 Anhui Provincial Cancer Hospital · Hefei · NCT07667751

• Gefitinib, trametinib, disulfiram, and sunitinib added to standard chemotherapy for metastatic osteosarcoma

  This study tests whether adding gefitinib, trametinib, disulfiram, and sunitinib to standard chemotherapy helps people with newly diagnosed metastatic osteosarcoma.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07477457

• IDRX-42 versus sunitinib for adults with advanced gastrointestinal stromal tumors after imatinib

  This test compares IDRX-42 (GSK6042981) with sunitinib in adults with advanced or unresectable GIST who have already been treated with imatinib to see which controls the cancer better and is safer.

  Recruiting at 156 sites Phase 3 GlaxoSmithKline · Phoenix, Arizona and 155 other locations · NCT07218926

• Lenvatinib for advanced GIST after imatinib, sunitinib, and regorafenib

  This trial tests whether the oral drug lenvatinib can help people with metastatic or advanced GIST whose disease has progressed on imatinib, sunitinib, and regorafenib.

  Recruiting Phase 1/2 Asan Medical Center · Seoul · NCT07096609

• Combining Palbociclib and Sunitinib for treating advanced solid tumors

  This study is testing if a combination of two cancer drugs, Palbociclib and Sunitinib, can help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting Phase 1/2 Rabin Medical Center · Petah Tikva · NCT06940349

• Oral Liporaxel (paclitaxel) treatment for gastrointestinal stromal tumors

  This study will test whether taking oral Liporaxel (a form of paclitaxel) can help people with advanced GIST who stopped responding to imatinib, sunitinib, and regorafenib and whose tumors have low P‑glycoprotein levels.

  Recruiting Phase 2 Asan Medical Center · Seoul, Songpagu · NCT06326346

• Evaluating bicalutamide and sunitinib for advanced kidney cancer

  This study is testing if a combination of two medications, bicalutamide and sunitinib, can help people with advanced kidney cancer who have not responded to previous treatments.

  Recruiting Phase 1/2 State University of New York at Buffalo · Buffalo, New York · NCT06222593

• Combination of rivoceranib and paclitaxel for advanced gastrointestinal stromal tumors

  This study is testing if a new combination of two drugs, rivoceranib and paclitaxel, can help adults with advanced gastrointestinal stromal tumors that haven't improved with standard treatments.

  Recruiting Phase 2 Asan Medical Center · Seoul, Seoul · NCT05905887

• Comparing two treatments for metastatic midgut neuroendocrine tumors

  This study is testing whether a retreatment with a specific type of radiation therapy or a daily pill works better for people with advanced midgut neuroendocrine tumors who have already had radiation therapy before.

  Recruiting at 40 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 42 other locations · NCT05773274

• Combining Sunitinib with Lutetium Lu 177 Dotatate for Pancreatic Neuroendocrine Tumors

  This study is testing if combining two treatments, sunitinib and lutetium Lu 177 dotatate, can help people with advanced pancreatic neuroendocrine tumors live longer and feel better.

  Recruiting at 8 sites Phase 1 National Cancer Institute (NCI) · Duarte, California and 9 other locations · NCT05687123

• Using DNA changes to guide treatment for gastrointestinal stromal tumors

  This study is testing if changes in a specific gene can help doctors decide the best treatment for patients with gastrointestinal stromal tumors who haven't responded well to other therapies.

  Recruiting Phase 2 University of Miami · Miami, Florida · NCT05366816

• (Peak) CGT9486 plus Sunitinib vs Sunitinib in advanced or metastatic GIST

  This study tests whether adding CGT9486 to sunitinib helps people with advanced or metastatic GIST who have already tried other treatments.

  Recruiting at 8 sites Phase 3 Cogent Biosciences, Inc. · Birmingham, Alabama and 125 other locations · NCT05208047

• Evaluating Cabozantinib and Temozolomide for Lung and GEP Neuroendocrine Tumors

  This study is testing if combining two medications, Cabozantinib and Temozolomide, can help people with advanced lung and gastroenteropancreatic neuroendocrine tumors who haven't responded to other treatments.

  Recruiting Phase 2 National Cancer Institute, Naples · Naples, Campania · NCT04893785

• Combining Losartan and Sunitinib for Osteosarcoma Treatment

  This study is testing if combining two medications, Losartan and Sunitinib, can help people aged 10 and older with osteosarcoma that hasn't responded to previous treatments.

  Recruiting at 4 sites Phase 1 University of Colorado, Denver · Los Angeles, California and 3 other locations · NCT03900793

Quick answers

How many clinical trials of Sunitinib are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 27 countries. The most sites are in United States (8 trials), South Korea (5 trials), Canada (4 trials), Italy (3 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 8, Phase 1/2: 3, Phase 3: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →